Glenview Capital Issues Statement on CVS Health. PR Newswire. NEW YORK, May 6, 2025. NEW YORK, May 6, 2025 /PRNewswire/ -- One year ago, we established a concentrated position in shares of CVS ...

CVS Health (CVS) stock in focus as Glenview Capital trims a third of its stake after the company's Q1 2025 earnings beat. Read more here.

Activist investor Glenview Capital Management sold 3.75 million shares of CVS Health Corp. — about a third of its stake — and said it was pleased with recent changes at the health care ...

Another credited Glenview Capital CEO Larry Robbins for the results. ... CVS reported Q4 adjusted earnings per share (EPS) of $1.19, beating the $0.91 estimate, with nearly $98 billion in revenue.

CVS Health Corp., based in Woonsocket ... They included the CEO of shareholder Glenview Capital Management, ... Glenview holds about 1% of the company’s outstanding shares, according to FactSet.

Glenview Capital Issues Statement on CVS Health. May 06, 2025 4:15 PM ET CVS Health Corporation (CVS) Q1: 2025-05-01 Earnings Summary. Insights Transcript Insights Transcript PR.

CVS Health steered through rising costs in its insurance division to handily beat profit expectations on Wall Street. The drugstore chain and pharmacy benefits manager earned $1.64 billion, or $1.

NEW YORK, May 6, 2025 /PRNewswire/ -- One year ago, we established a concentrated position in shares of CVS Health (NYSE: CVS). Since our purchases in May 2024, CVS shares ...

CVS Health steered through rising costs in its insurance division to handily beat profit expectations on Wall Street. ... They included the CEO of shareholder Glenview Capital Management, ...